Search

everythinglearnresearchcommunity

for

Search:↓

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

Male hormones worsen kidney transplant damage, but blocking them helps.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Anabolic steroid users may face higher risk of severe COVID-19.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.